What can you see tonight?

With enpatoran soon entering Phase III clinical trials, the Phase II safety and efficacy results support the drug’s development.

Last month, C4 Therapeutics dosed the first patient in its Phase II MOMENTUM trial of cemsidomide, combined with ...

Viridian Therapeutics Inc. (VRDN) shares tanked more than 41% in Monday’s pre-market trade after the company announced results from its Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease.

While orbiting Earth, the moon undergoes a series of phases, each marked by its unique appearance in the sky The moon has captivated humanity since the beginning of time, but what deeper significance ...

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...